Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Seagen Inc. (SGEN) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Seagen Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1060736.
Total stock buying since 2014: $1,160,479,679.
Total stock sales since 2014: $1,004,689,522.
Total stock option exercises since 2014: $71,753,696.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 0 | $0 | 392,914 | $73,193,732 | 322,898 | $16,265,420 |
| 2022 | 0 | $0 | 250,716 | $37,014,358 | 234,844 | $7,144,665 |
| 2021 | 0 | $0 | 968,655 | $156,502,918 | 465,023 | $11,080,930 |
| 2020 | 0 | $0 | 3,776,313 | $607,190,520 | 685,142 | $14,851,091 |
| 2019 | 0 | $0 | 532,740 | $44,228,990 | 430,833 | $6,089,430 |
| 2018 | 5,306,804 | $275,895,222 | 375,703 | $24,277,576 | 373,126 | $4,469,898 |
| 2017 | 0 | $0 | 425,707 | $24,086,518 | 375,862 | $4,731,181 |
| 2016 | 6,200,638 | $257,974,072 | 373,779 | $18,628,401 | 407,265 | $4,207,373 |
| 2015 | 9,422,008 | $389,855,263 | 381,027 | $15,900,526 | 277,285 | $2,245,552 |
| 2014 | 7,019,620 | $236,755,122 | 89,351 | $3,665,983 | 86,333 | $668,156 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-11-16 | Dobmeier Eric (Chief Operating Officer) | Sale | 15,400 | 57.97 | 892,661 |
| 2017-11-16 | Dobmeier Eric (Chief Operating Officer) | Option Ex | 15,400 | 20.78 | 320,012 |
| 2017-11-15 | Lippman Marc E (Director) | Sale | 3,000 | 58.08 | 174,225 |
| 2017-11-15 | Dobmeier Eric (Chief Operating Officer) | Sale | 9,600 | 57.80 | 554,841 |
| 2017-11-15 | Dobmeier Eric (Chief Operating Officer) | Option Ex | 9,600 | 15.46 | 148,416 |
| 2017-11-10 | Siegall Clay B (President and CEO) | Sale | 18,832 | 58.20 | 1,096,116 |
| 2017-11-10 | Siegall Clay B (President and CEO) | Option Ex | 18,832 | 11.09 | 208,846 |
| 2017-11-01 | Simpson Todd E (Chief Financial Officer) | Sale | 39,385 | 61.24 | 2,412,134 |
| 2017-10-11 | Siegall Clay B (President and CEO) | Sale | 18,832 | 60.57 | 1,140,710 |
| 2017-10-11 | Siegall Clay B (President and CEO) | Option Ex | 18,832 | 11.09 | 208,846 |
| 2017-10-05 | Drachman Jonathan G (CMO & EVP, R & D) | Option Ex | 17,816 | 11.29 | 201,089 |
| 2017-09-26 | Siegall Clay B (President and CEO) | Option Ex | 9,017 | 11.09 | 99,998 |
| 2017-09-11 | Siegall Clay B (President and CEO) | Sale | 18,832 | 53.78 | 1,012,879 |
| 2017-09-11 | Siegall Clay B (President and CEO) | Option Ex | 18,832 | 11.09 | 208,846 |
| 2017-09-08 | Himes Vaughn B (Chief Technical Officer) | Sale | 10,000 | 53.09 | 530,850 |
| 2017-09-08 | Himes Vaughn B (Chief Technical Officer) | Option Ex | 10,000 | 10.70 | 106,950 |
| 2017-09-06 | Cline Darren S (EVP, Commercial) | Sale | 5,024 | 51.94 | 260,966 |
| 2017-09-06 | Cline Darren S (EVP, Commercial) | Option Ex | 10,048 | 15.94 | 160,114 |
| 2017-09-06 | Simpson Todd E (Chief Financial Officer) | Sale | 9,638 | 52.00 | 501,176 |
| 2017-08-31 | Cline Darren S (EVP, Commercial) | Sale | 7,569 | 52.51 | 397,478 |
| 2017-08-31 | Cline Darren S (EVP, Commercial) | Option Ex | 2,907 | 18.46 | 53,663 |
| 2017-08-31 | Dobmeier Eric (Chief Operating Officer) | Sale | 25,000 | 52.24 | 1,305,900 |
| 2017-08-31 | Dobmeier Eric (Chief Operating Officer) | Option Ex | 25,000 | 15.46 | 386,500 |
| 2017-08-28 | Cline Darren S (EVP, Commercial) | Sale | 1,788 | 47.90 | 85,636 |
| 2017-08-28 | Drachman Jonathan G (CMO & EVP, R & D) | Sale | 8,502 | 47.90 | 407,203 |
| 2017-08-28 | Himes Vaughn B (Chief Technical Officer) | Sale | 6,377 | 47.90 | 305,426 |
| 2017-08-28 | Simpson Todd E (Chief Financial Officer) | Sale | 4,937 | 47.90 | 236,457 |
| 2017-08-28 | Dobmeier Eric (Chief Operating Officer) | Sale | 5,343 | 47.90 | 255,902 |
| 2017-08-28 | Siegall Clay B (President and CEO) | Sale | 25,506 | 47.90 | 1,221,609 |
| 2017-08-24 | Drachman Jonathan G (CMO & EVP, R & D) | Sale | 10,000 | 47.54 | 475,409 |
| 2017-08-24 | Drachman Jonathan G (CMO & EVP, R & D) | Option Ex | 10,000 | 10.29 | 102,899 |
| 2017-08-07 | Cline Darren S (EVP, Commercial) | Sale | 6,000 | 49.19 | 295,110 |
| 2017-08-07 | Cline Darren S (EVP, Commercial) | Option Ex | 6,000 | 18.46 | 110,760 |
| 2017-08-07 | Siegall Clay B (President and CEO) | Sale | 10,413 | 48.91 | 509,299 |
| 2017-08-07 | Siegall Clay B (President and CEO) | Option Ex | 10,413 | 10.29 | 107,149 |
| 2017-07-27 | Drachman Jonathan G (CMO & EVP, R & D) | Sale | 10,000 | 54.54 | 545,360 |
| 2017-07-27 | Drachman Jonathan G (CMO & EVP, R & D) | Option Ex | 10,000 | 10.29 | 102,899 |
| 2017-07-05 | Siegall Clay B (President and CEO) | Sale | 10,423 | 52.15 | 543,507 |
| 2017-07-05 | Siegall Clay B (President and CEO) | Option Ex | 10,423 | 10.29 | 107,252 |
| 2017-06-22 | Drachman Jonathan G (CMO & EVP, R & D) | Sale | 10,000 | 64.29 | 642,900 |
| 2017-06-22 | Drachman Jonathan G (CMO & EVP, R & D) | Option Ex | 10,000 | 10.29 | 102,899 |
| 2017-06-05 | Siegall Clay B (President and CEO) | Sale | 10,423 | 65.50 | 682,654 |
| 2017-06-05 | Siegall Clay B (President and CEO) | Option Ex | 10,423 | 10.29 | 107,252 |
| 2017-05-15 | Baker Brothers Life Sciences Lp (Director) | Option Ex | 20,000 | 10.20 | 204,000 |
| 2017-05-05 | Siegall Clay B (President and CEO) | Sale | 14,462 | 62.48 | 903,629 |
| 2017-05-05 | Siegall Clay B (President and CEO) | Option Ex | 14,462 | 10.27 | 148,481 |
| 2017-04-05 | Siegall Clay B (President and CEO) | Sale | 14,465 | 62.75 | 907,678 |
| 2017-04-05 | Siegall Clay B (President and CEO) | Option Ex | 14,465 | 10.23 | 147,976 |
| 2017-03-31 | Himes Vaughn B (Chief Technical Officer) | Sale | 10,000 | 62.75 | 627,530 |
| 2017-03-31 | Himes Vaughn B (Chief Technical Officer) | Option Ex | 10,000 | 9.23 | 92,300 |
| 2017-03-06 | Siegall Clay B (President and CEO) | Sale | 14,465 | 67.90 | 982,173 |
| 2017-03-06 | Siegall Clay B (President and CEO) | Option Ex | 14,465 | 10.23 | 147,976 |
| 2017-02-06 | Siegall Clay B (President and CEO) | Sale | 14,465 | 61.78 | 893,604 |
| 2017-02-06 | Siegall Clay B (President and CEO) | Option Ex | 14,465 | 10.26 | 148,410 |
| 2017-01-25 | Drachman Jonathan G (CMO & EVP, R & D) | Option Ex | 5,000 | 10.29 | 51,449 |
| 2017-01-06 | Siegall Clay B (President and CEO) | Sale | 14,465 | 57.82 | 836,337 |
| 2017-01-06 | Siegall Clay B (President and CEO) | Option Ex | 14,465 | 10.25 | 148,324 |
| 2016-12-16 | Cline Darren S (EVP, Commercial) | Option Ex | 3,100 | 16.41 | 50,871 |
| 2016-12-13 | Cline Darren S (EVP, Commercial) | Sale | 10,000 | 63.80 | 638,010 |
| 2016-12-13 | Cline Darren S (EVP, Commercial) | Option Ex | 12,761 | 22.28 | 284,315 |
| 2016-12-12 | Himes Vaughn B (Chief Technical Officer) | Option Ex | 15,632 | 17.85 | 279,078 |
| 2016-12-08 | Dobmeier Eric (Chief Operating Officer) | Sale | 12,500 | 65.95 | 824,400 |
| 2016-12-08 | Dobmeier Eric (Chief Operating Officer) | Option Ex | 12,500 | 20.52 | 256,500 |
| 2016-12-07 | Himes Vaughn B (Chief Technical Officer) | Sale | 30,000 | 65.69 | 1,970,550 |
| 2016-12-07 | Himes Vaughn B (Chief Technical Officer) | Option Ex | 30,000 | 9.23 | 276,900 |
| 2016-12-06 | Siegall Clay B (President and CEO) | Sale | 14,465 | 66.03 | 955,080 |
| 2016-12-06 | Siegall Clay B (President and CEO) | Option Ex | 14,465 | 10.24 | 148,193 |
| 2016-11-09 | Drachman Jonathan G (CMO & EVP, R & D) | Sale | 7,751 | 66.75 | 517,379 |
| 2016-11-09 | Drachman Jonathan G (CMO & EVP, R & D) | Option Ex | 7,751 | 11.09 | 85,958 |
| 2016-11-08 | Baker Brothers Life Sciences Lp (Director) | Buy | 326,300 | 59.47 | 19,403,429 |
| 2016-11-07 | Baker Brothers Life Sciences Lp (Director) | Buy | 56,200 | 58.74 | 3,301,356 |
| 2016-11-07 | Lippman Marc E (Director) | Sale | 1,000 | 57.75 | 57,749 |
| 2016-11-07 | Siegall Clay B (President and CEO) | Sale | 14,465 | 57.87 | 837,060 |
| 2016-11-07 | Siegall Clay B (President and CEO) | Option Ex | 14,465 | 10.24 | 148,193 |
| 2016-11-03 | Baker Brothers Life Sciences Lp (Director) | Buy | 577,769 | 56.54 | 32,700,636 |
| 2016-11-02 | Baker Brothers Life Sciences Lp (Director) | Buy | 466,619 | 56.04 | 26,151,195 |
| 2016-11-01 | Drachman Jonathan G (CMO & EVP, R & D) | Sale | 3,418 | 51.74 | 176,847 |
| 2016-11-01 | Baker Brothers Life Sciences Lp (Director) | Buy | 184,674 | 53.89 | 9,952,266 |
| 2016-10-06 | Siegall Clay B (President and CEO) | Sale | 14,465 | 54.41 | 787,026 |
| 2016-10-06 | Siegall Clay B (President and CEO) | Option Ex | 14,465 | 10.24 | 148,193 |
| 2016-09-22 | Drachman Jonathan G (CMO & EVP, R & D) | Sale | 2,249 | 56.75 | 127,630 |
| 2016-09-22 | Drachman Jonathan G (CMO & EVP, R & D) | Option Ex | 2,249 | 10.29 | 23,142 |
| 2016-09-14 | Dobmeier Eric (Chief Operating Officer) | Sale | 22,918 | 54.22 | 1,242,705 |
| 2016-09-14 | Dobmeier Eric (Chief Operating Officer) | Option Ex | 22,918 | 12.00 | 275,016 |
| 2016-09-13 | Baker Brothers Life Sciences Lp (Director) | Buy | 141,202 | 50.74 | 7,164,024 |
| 2016-09-12 | Baker Brothers Life Sciences Lp (Director) | Buy | 49,889 | 50.64 | 2,526,378 |
| 2016-09-09 | Cline Darren S (EVP, Commercial) | Option Ex | 4,167 | 15.46 | 64,421 |
| 2016-09-09 | Baker Brothers Life Sciences Lp (Director) | Buy | 256,220 | 50.58 | 12,958,326 |
| 2016-09-08 | Baker Brothers Life Sciences Lp (Director) | Buy | 211,093 | 49.85 | 10,523,830 |
| 2016-09-08 | Siegall Clay B (President and CEO) | Sale | 31,269 | 50.08 | 1,565,982 |
| 2016-09-08 | Siegall Clay B (President and CEO) | Option Ex | 31,269 | 10.29 | 321,758 |
| 2016-09-07 | Baker Brothers Life Sciences Lp (Director) | Buy | 59,560 | 48.29 | 2,875,914 |
| 2016-09-06 | Cline Darren S (EVP, Commercial) | Sale | 5,397 | 46.01 | 248,326 |
| 2016-09-06 | Baker Brothers Life Sciences Lp (Director) | Buy | 143,363 | 45.59 | 6,536,062 |
| 2016-09-06 | Gryska David W (Director) | Option Ex | 10,000 | 10.20 | 102,000 |
| 2016-09-06 | Siegall Clay B (President and CEO) | Sale | 11,653 | 45.30 | 527,892 |
| 2016-09-06 | Siegall Clay B (President and CEO) | Option Ex | 23,957 | 7.92 | 189,691 |
| 2016-08-23 | Dobmeier Eric (Chief Operating Officer) | Sale | 12,589 | 48.00 | 604,272 |
| 2016-08-23 | Dobmeier Eric (Chief Operating Officer) | Option Ex | 3,831 | 26.10 | 99,989 |
| 2016-08-22 | Cline Darren S (EVP, Commercial) | Sale | 1,774 | 46.59 | 82,652 |
| 2016-08-22 | Drachman Jonathan G (CMO & EVP, R & D) | Sale | 3,991 | 46.59 | 185,944 |
| 2016-08-22 | Himes Vaughn B (EVP, Proc Svcs & Tech Ops) | Sale | 3,991 | 46.59 | 185,944 |
| 2016-08-22 | Simpson Todd E (Chief Financial Officer) | Sale | 3,991 | 46.59 | 185,944 |
| 2016-08-22 | Dobmeier Eric (Chief Operating Officer) | Sale | 5,411 | 46.59 | 252,103 |
| 2016-08-22 | Siegall Clay B (President and CEO) | Sale | 23,381 | 46.59 | 1,089,344 |
| 2016-08-08 | Siegall Clay B (President and CEO) | Sale | 11,660 | 47.12 | 549,477 |
| 2016-08-08 | Siegall Clay B (President and CEO) | Option Ex | 11,660 | 7.33 | 85,409 |
| 2016-07-27 | Siegall Clay B (President and CEO) | Sale | 4,042 | 45.20 | 182,718 |
| 2016-07-27 | Siegall Clay B (President and CEO) | Option Ex | 4,042 | 10.20 | 41,228 |
| 2016-07-06 | Siegall Clay B (President and CEO) | Sale | 7,618 | 40.44 | 308,071 |
| 2016-07-06 | Siegall Clay B (President and CEO) | Option Ex | 7,618 | 4.45 | 33,900 |
| 2016-06-06 | Siegall Clay B (President and CEO) | Sale | 22,083 | 43.57 | 962,222 |
| 2016-06-06 | Siegall Clay B (President and CEO) | Option Ex | 22,083 | 8.31 | 183,575 |
| 2016-06-02 | Cline Darren S (EVP, Commercial) | Sale | 3,366 | 42.07 | 141,617 |
| 2016-06-02 | Drachman Jonathan G (CMO & EVP, R & D) | Option Ex | 5,000 | 10.29 | 51,449 |
| 2016-05-27 | Siegall Clay B (President and CEO) | Sale | 10,792 | 40.10 | 432,813 |
| 2016-05-27 | Siegall Clay B (President and CEO) | Option Ex | 10,792 | 10.29 | 111,049 |
| 2016-05-26 | Siegall Clay B (President and CEO) | Sale | 1,130 | 40.07 | 45,283 |
| 2016-05-26 | Siegall Clay B (President and CEO) | Option Ex | 1,130 | 10.29 | 11,627 |
| 2016-05-25 | Siegall Clay B (President and CEO) | Sale | 36,738 | 40.51 | 1,488,293 |
| 2016-05-25 | Siegall Clay B (President and CEO) | Option Ex | 36,738 | 10.24 | 376,380 |
| 2016-05-24 | Siegall Clay B (President and CEO) | Sale | 1,700 | 40.00 | 68,000 |
| 2016-05-24 | Siegall Clay B (President and CEO) | Option Ex | 1,700 | 10.20 | 17,340 |
| 2016-05-23 | Siegall Clay B (President and CEO) | Sale | 6,700 | 40.12 | 268,777 |
| 2016-05-23 | Siegall Clay B (President and CEO) | Option Ex | 6,700 | 10.20 | 68,340 |
| 2016-05-17 | Siegall Clay B (President and CEO) | Sale | 7,618 | 35.16 | 267,848 |
| 2016-05-17 | Siegall Clay B (President and CEO) | Option Ex | 7,618 | 4.45 | 33,900 |
| 2016-04-25 | Siegall Clay B (President and CEO) | Sale | 800 | 40.00 | 32,000 |
| 2016-04-25 | Siegall Clay B (President and CEO) | Option Ex | 800 | 10.20 | 8,159 |
| 2016-04-05 | Siegall Clay B (President and CEO) | Sale | 7,618 | 36.12 | 275,162 |
| 2016-04-05 | Siegall Clay B (President and CEO) | Option Ex | 7,618 | 4.45 | 33,900 |
| 2016-03-22 | Siegall Clay B (President and CEO) | Sale | 10,954 | 35.91 | 393,369 |
| 2016-03-22 | Siegall Clay B (President and CEO) | Option Ex | 10,954 | 4.45 | 48,745 |
| 2016-03-21 | Siegall Clay B (President and CEO) | Sale | 4,282 | 35.01 | 149,912 |
| 2016-03-21 | Siegall Clay B (President and CEO) | Option Ex | 4,282 | 4.45 | 19,054 |
| 2016-03-17 | Baker Brothers Life Sciences Lp (Director) | Buy | 124,065 | 32.07 | 3,978,392 |
| 2016-03-16 | Baker Brothers Life Sciences Lp (Director) | Buy | 569,203 | 31.71 | 18,050,565 |
| 2016-03-15 | Baker Brothers Life Sciences Lp (Director) | Buy | 661,093 | 31.85 | 21,057,134 |
| 2016-03-14 | Baker Brothers Life Sciences Lp (Director) | Buy | 118,941 | 33.77 | 4,016,518 |
| 2016-03-11 | Baker Brothers Life Sciences Lp (Director) | Buy | 195,765 | 32.82 | 6,424,811 |
| 2016-03-10 | Baker Brothers Life Sciences Lp (Director) | Buy | 290,231 | 32.35 | 9,390,424 |
| 2016-03-09 | Baker Brothers Life Sciences Lp (Director) | Buy | 208,670 | 31.91 | 6,659,494 |
| 2016-03-08 | Baker Brothers Life Sciences Lp (Director) | Buy | 153,200 | .00 | 0 |
| 2016-03-08 | Baker Brothers Life Sciences Lp (Director) | Option Ex | 20,000 | 4.18 | 83,600 |
| 2016-03-08 | Welch Daniel G (Director) | Option Ex | 25,000 | 9.82 | 245,500 |
| 2016-03-07 | Baker Brothers Life Sciences Lp (Director) | Buy | 61,265 | 33.70 | 2,064,630 |
| 2016-03-04 | Baker Brothers Life Sciences Lp (Director) | Buy | 288,058 | 32.09 | 9,242,917 |
| 2016-03-02 | Baker Brothers Life Sciences Lp (Director) | Buy | 400,000 | 32.50 | 12,999,600 |
| 2016-03-01 | Baker Brothers Life Sciences Lp (Director) | Buy | 24,200 | 31.24 | 756,104 |
| 2016-02-29 | Baker Brothers Life Sciences Lp (Director) | Buy | 251,722 | 30.45 | 7,663,676 |
| 2016-02-12 | Orwin John A (Director) | Buy | 2,000 | 28.33 | 56,660 |
| 2015-12-18 | Himes Vaughn B (EVP, Proc Svcs & Tech Ops) | Option Ex | 35,036 | 10.62 | 371,907 |
| 2015-12-15 | Himes Vaughn B (EVP, Proc Svcs & Tech Ops) | Sale | 40,500 | 39.94 | 1,617,489 |
| 2015-12-15 | Himes Vaughn B (EVP, Proc Svcs & Tech Ops) | Option Ex | 40,500 | 9.23 | 373,815 |
| 2015-12-03 | Siegall Clay B (President and CEO) | Sale | 3,720 | 39.99 | 148,762 |
| 2015-12-03 | Siegall Clay B (President and CEO) | Option Ex | 3,720 | 5.63 | 20,943 |
| 2015-11-20 | Baker Brothers Life Sciences Lp (Director) | Buy | 181,647 | 43.93 | 7,980,297 |
| 2015-11-19 | Baker Brothers Life Sciences Lp (Director) | Buy | 133,073 | 43.93 | 5,845,364 |
| 2015-11-18 | Baker Brothers Life Sciences Lp (Director) | Buy | 14,638 | 43.42 | 635,552 |
| 2015-11-17 | Siegall Clay B (President and CEO) | Sale | 87,473 | 45.40 | 3,970,924 |
| 2015-11-11 | Cline Darren S (SVP, Commercial) | Sale | 5,769 | 45.68 | 263,545 |
| 2015-11-10 | Baker Brothers Life Sciences Lp (Director) | Buy | 9,400 | 44.00 | 413,600 |
| 2015-11-09 | Baker Brothers Life Sciences Lp (Director) | Buy | 507,300 | 43.57 | 22,102,553 |
| 2015-11-06 | Baker Brothers Life Sciences Lp (Director) | Buy | 417,924 | 41.91 | 17,514,776 |
| 2015-11-06 | Dobmeier Eric (Chief Operating Officer) | Sale | 17,452 | 42.50 | 741,710 |
| 2015-11-05 | Gryska David W (Director) | Sale | 10,000 | 43.57 | 435,740 |
| 2015-11-04 | Siegall Clay B (President and CEO) | Sale | 3,718 | 43.14 | 160,394 |
| 2015-11-04 | Siegall Clay B (President and CEO) | Option Ex | 3,718 | 5.63 | 20,932 |
| 2015-10-28 | Siegall Clay B (President and CEO) | Option Ex | 32,265 | 5.04 | 162,615 |
| 2015-10-05 | Siegall Clay B (President and CEO) | Sale | 3,718 | 41.30 | 153,542 |
| 2015-10-05 | Siegall Clay B (President and CEO) | Option Ex | 3,718 | 5.63 | 20,932 |
| 2015-09-29 | Simpson Todd E (Chief Financial Officer) | Option Ex | 14,801 | 13.73 | 203,217 |
| 2015-09-15 | Baker Brothers Life Sciences Lp (Director) | Buy | 626,259 | 47.64 | 29,837,483 |
| 2015-09-14 | Baker Brothers Life Sciences Lp (Director) | Buy | 320,438 | 45.76 | 14,663,883 |
| 2015-09-11 | Baker Brothers Life Sciences Lp (Director) | Buy | 4,212,787 | 42.49 | 179,009,745 |
| 2015-09-03 | Siegall Clay B (President and CEO) | Sale | 3,718 | 40.12 | 149,166 |
| 2015-09-03 | Siegall Clay B (President and CEO) | Option Ex | 3,718 | 5.63 | 20,932 |
| 2015-08-24 | Dobmeier Eric (Chief Operating Officer) | Option Ex | 9,866 | 17.99 | 177,488 |
| 2015-08-20 | Cline Darren S (SVP, Commercial) | Sale | 4,462 | 42.02 | 187,514 |
| 2015-08-20 | Drachman Jonathan G (CMO & EVP, R & D) | Sale | 4,462 | 42.02 | 187,511 |
| 2015-08-20 | Himes Vaughn B (EVP, Proc Svcs & Tech Ops) | Sale | 5,997 | 42.02 | 252,023 |
| 2015-08-20 | Simpson Todd E (Chief Financial Officer) | Sale | 5,825 | 42.02 | 244,795 |
| 2015-08-20 | Dobmeier Eric (Chief Operating Officer) | Sale | 17,096 | 42.02 | 718,458 |
| 2015-08-20 | Siegall Clay B (President and CEO) | Sale | 31,754 | 42.02 | 1,334,430 |
| 2015-08-05 | Siegall Clay B (President and CEO) | Sale | 3,718 | 46.91 | 174,411 |
| 2015-08-05 | Siegall Clay B (President and CEO) | Option Ex | 3,718 | 5.63 | 20,932 |
| 2015-07-06 | Siegall Clay B (President and CEO) | Sale | 3,718 | 46.94 | 174,515 |
| 2015-07-06 | Siegall Clay B (President and CEO) | Option Ex | 3,718 | 5.63 | 20,932 |
| 2015-06-03 | Siegall Clay B (President and CEO) | Sale | 3,718 | 45.72 | 169,972 |
| 2015-06-03 | Siegall Clay B (President and CEO) | Option Ex | 3,718 | 5.63 | 20,932 |
| 2015-05-21 | Baker Brothers Life Sciences Lp (Director) | Buy | 362,459 | 43.46 | 15,753,555 |
| 2015-05-20 | Baker Brothers Life Sciences Lp (Director) | Buy | 374,298 | 42.07 | 15,745,219 |
| 2015-05-19 | Baker Brothers Life Sciences Lp (Director) | Buy | 214,129 | 40.91 | 8,759,375 |
| 2015-05-11 | Baker Brothers Life Sciences Lp (Director) | Option Ex | 20,000 | 5.11 | 102,200 |
| 2015-05-08 | Dobmeier Eric (Chief Operating Officer) | Sale | 17,074 | 40.38 | 689,379 |
| 2015-05-08 | Siegall Clay B (President and CEO) | Sale | 52,052 | 40.65 | 2,116,069 |
| 2015-05-08 | Siegall Clay B (President and CEO) | Option Ex | 52,052 | 5.63 | 293,052 |
| 2015-05-07 | Baker Brothers Life Sciences Lp (Director) | Buy | 47,717 | 37.11 | 1,770,873 |
| 2015-05-06 | Baker Brothers Life Sciences Lp (Director) | Buy | 453,995 | 36.22 | 16,441,882 |
| 2015-05-05 | Baker Brothers Life Sciences Lp (Director) | Buy | 530,952 | 34.49 | 18,312,003 |
| 2015-04-08 | Gryska David W (Director) | Option Ex | 5,000 | 8.38 | 41,900 |
| 2015-03-13 | Cline Darren S (SVP, Commercial) | Sale | 7,500 | 38.65 | 289,875 |
| 2015-03-12 | Himes Vaughn B (EVP, Proc Svcs & Tech Ops) | Sale | 20,000 | 36.65 | 733,000 |
| 2015-03-12 | Himes Vaughn B (EVP, Proc Svcs & Tech Ops) | Option Ex | 20,000 | 9.23 | 184,600 |
| 2015-03-10 | Baker Brothers Life Sciences Lp (Director) | Buy | 9,319 | 34.59 | 322,362 |
| 2015-03-09 | Baker Brothers Life Sciences Lp (Director) | Buy | 275,717 | 34.66 | 9,555,248 |
| 2015-03-04 | Baker Brothers Life Sciences Lp (Director) | Buy | 23,621 | 34.81 | 822,152 |
| 2015-03-03 | Baker Brothers Life Sciences Lp (Director) | Buy | 425,220 | 34.84 | 14,815,090 |
| 2015-02-25 | Baker Brothers Life Sciences Lp (Director) | Buy | 63,650 | 35.03 | 2,229,595 |
| 2015-02-24 | Baker Brothers Life Sciences Lp (Director) | Buy | 217,465 | 33.68 | 7,324,656 |
| 2015-01-06 | Siegall Clay B (President and CEO) | Sale | 16,804 | 31.80 | 534,316 |
| 2015-01-06 | Siegall Clay B (President and CEO) | Option Ex | 16,804 | 5.92 | 99,479 |
| 2014-12-16 | Baker Brothers Life Sciences Lp (Director) | Buy | 1,909,979 | 31.63 | 60,418,365 |
| 2014-12-15 | Baker Brothers Life Sciences Lp (Director) | Buy | 973,399 | 31.62 | 30,774,982 |
| 2014-12-10 | 14159, L.p. (Director) | Buy | 654,150 | 34.52 | 22,582,566 |
| 2014-12-09 | 14159, L.p. (Director) | Buy | 128,430 | 33.94 | 4,359,042 |
| 2014-12-08 | 14159, L.p. (Director) | Buy | 465,316 | 32.98 | 15,347,517 |
| 2014-11-12 | Himes Vaughn B (EVP, Tech. Ops. & Proc. Sci.) | Sale | 10,000 | 37.52 | 375,170 |
| 2014-11-12 | Himes Vaughn B (EVP, Tech. Ops. & Proc. Sci.) | Option Ex | 10,000 | 9.23 | 92,300 |
| 2014-11-10 | 14159, L.p. (Director) | Buy | 241,249 | 36.49 | 8,802,211 |
| 2014-11-07 | 14159, L.p. (Director) | Buy | 211,704 | 35.53 | 7,522,266 |
| 2014-11-06 | 14159, L.p. (Director) | Buy | 1,200,972 | 34.26 | 41,150,104 |
| 2014-09-04 | Siegall Clay B (President and CEO) | Sale | 5,600 | 42.54 | 238,224 |
| 2014-09-04 | Siegall Clay B (President and CEO) | Option Ex | 5,600 | 5.92 | 33,152 |
| 2014-08-27 | Dobmeier Eric (Chief Operating Officer) | Option Ex | 8,333 | 12.00 | 99,996 |
| 2014-08-25 | Dobmeier Eric (Chief Operating Officer) | Sale | 4,818 | 43.55 | 209,819 |
| 2014-08-24 | Drachman Jonathan G (CMO & EVP, R & D) | Sale | 2,772 | 43.55 | 120,717 |
| 2014-08-24 | Boerner Christopher S. (Executive Vice President, Comm) | Sale | 1,248 | 43.55 | 54,349 |
| 2014-08-24 | Himes Vaughn B (EVP, Tech. Ops. & Proc. Sci.) | Sale | 3,310 | 43.55 | 144,147 |
| 2014-08-24 | Simpson Todd E (Chief Financial Officer) | Sale | 3,696 | 43.55 | 160,957 |
| 2014-08-24 | Siegall Clay B (President and CEO) | Sale | 25,507 | 43.55 | 1,110,804 |
| 2014-08-12 | Siegall Clay B (President and CEO) | Sale | 8,500 | 40.48 | 344,088 |
| 2014-08-12 | Siegall Clay B (President and CEO) | Option Ex | 8,500 | 5.92 | 50,320 |
| 2014-08-11 | Siegall Clay B (President and CEO) | Sale | 2,700 | 40.05 | 108,129 |
| 2014-08-11 | Siegall Clay B (President and CEO) | Option Ex | 2,700 | 5.92 | 15,984 |
| 2014-06-13 | 14159, L.p. (Director) | Buy | 88,587 | 39.87 | 3,531,520 |
| 2014-06-12 | 14159, L.p. (Director) | Buy | 128,008 | 39.92 | 5,109,823 |
| 2014-06-10 | Siegall Clay B (President and CEO) | Sale | 11,200 | 40.14 | 449,579 |
| 2014-06-10 | Siegall Clay B (President and CEO) | Option Ex | 11,200 | 5.92 | 66,304 |
| 2014-06-09 | 14159, L.p. (Director) | Buy | 251,093 | 38.76 | 9,731,862 |
| 2014-06-06 | 14159, L.p. (Director) | Buy | 174,987 | 37.46 | 6,554,488 |
| 2014-06-05 | 14159, L.p. (Director) | Buy | 120,172 | 37.65 | 4,524,836 |
| 2014-06-04 | 14159, L.p. (Director) | Buy | 87,042 | 36.22 | 3,152,226 |
| 2014-06-03 | 14159, L.p. (Director) | Buy | 100,304 | 34.92 | 3,503,016 |
| 2014-06-02 | 14159, L.p. (Director) | Buy | 94,617 | 34.13 | 3,229,562 |
| 2014-05-16 | 14159, L.p. (Director) | Buy | 168,411 | 34.06 | 5,736,078 |
| 2014-05-15 | 14159, L.p. (Director) | Buy | 21,200 | 34.18 | 724,658 |
| 2014-05-14 | 14159, L.p. (Director) | Option Ex | 30,000 | 7.26 | 217,800 |
| 2014-05-09 | Himes Vaughn B (EVP, Tech. Ops. & Proc. Sci.) | Sale | 10,000 | 35.00 | 350,000 |
| 2014-05-09 | Himes Vaughn B (EVP, Tech. Ops. & Proc. Sci.) | Option Ex | 10,000 | 9.23 | 92,300 |
Insider trading activities including stock purchases, stock sales, and option exercises of SGEN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Seagen Inc. (symbol SGEN, CIK number 1060736) see the Securities and Exchange Commission (SEC) website.